Asset Allocation
3 Stock Sectors, All Tech, Expected to Soar in 2024
Why biotech, AI and cybersecurity should romp, per State Street.
Tag: biotechnology
Risk
Why Battered Biotech May Be Turning Around
This cyclical sector has suffered, post-pandemic, but signs of a recovery are appearing.
Alternatives
Mubadala and Others Pledge Big Money for UK-Based AI Drug Discovery Firm
Exscientia has just closed a $225 million Series D funding round, enlisting giant institutional investors.